CUL4B protects kidneys from acute injury by restraining p53/PAI-1 signaling.

IF 8.1 1区 生物学 Q1 CELL BIOLOGY Cell Death & Disease Pub Date : 2024-12-18 DOI:10.1038/s41419-024-07299-w
Kaixuan Liu, Xiaoyu Hao, Yangfan Gao, Zhiyuan Cao, Min Hou, Lining Qin, Yu Song, Molin Wang, Baichun Jiang, Qiao Liu, Yongxin Zou, Yaoqin Gong, Guangyi Liu, Gongping Sun
{"title":"CUL4B protects kidneys from acute injury by restraining p53/PAI-1 signaling.","authors":"Kaixuan Liu, Xiaoyu Hao, Yangfan Gao, Zhiyuan Cao, Min Hou, Lining Qin, Yu Song, Molin Wang, Baichun Jiang, Qiao Liu, Yongxin Zou, Yaoqin Gong, Guangyi Liu, Gongping Sun","doi":"10.1038/s41419-024-07299-w","DOIUrl":null,"url":null,"abstract":"<p><p>Acute kidney injury (AKI) caused by nephrotoxins, ischemia reperfusion (IR) or sepsis is associated with high morbidity and mortality. Unveiling new mechanisms underlying AKI can help develop new therapeutic strategy. Cullin 4B (CUL4B) is a scaffold protein in the CUL4B-RING E3 ubiquitin ligase (CRL4B) complex. Here, we demonstrate that CUL4B can protect kidneys from acute injury induced by cisplatin and IR. CUL4B is upregulated in mouse tubular epithelial cells (TECs) after cisplatin treatment or IR. Loss of CUL4B in kidneys exacerbates renal injury, inflammation, and apoptosis of TECs caused by cisplatin and IR. Transcriptome analysis reveals that Cul4b deficiency enhances injury-induced PAI-1 expression. CUL4B suppresses PAI-1 expression by promoting polyubiquitination and degradation of p53. Inhibition of either PAI-1 or p53 can prevent the aggravated renal injury and inflammation caused by loss of CUL4B. Our work has identified the kidney-protective role of CUL4B against acute injury.</p>","PeriodicalId":9734,"journal":{"name":"Cell Death & Disease","volume":"15 12","pages":"915"},"PeriodicalIF":8.1000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655551/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Death & Disease","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s41419-024-07299-w","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Acute kidney injury (AKI) caused by nephrotoxins, ischemia reperfusion (IR) or sepsis is associated with high morbidity and mortality. Unveiling new mechanisms underlying AKI can help develop new therapeutic strategy. Cullin 4B (CUL4B) is a scaffold protein in the CUL4B-RING E3 ubiquitin ligase (CRL4B) complex. Here, we demonstrate that CUL4B can protect kidneys from acute injury induced by cisplatin and IR. CUL4B is upregulated in mouse tubular epithelial cells (TECs) after cisplatin treatment or IR. Loss of CUL4B in kidneys exacerbates renal injury, inflammation, and apoptosis of TECs caused by cisplatin and IR. Transcriptome analysis reveals that Cul4b deficiency enhances injury-induced PAI-1 expression. CUL4B suppresses PAI-1 expression by promoting polyubiquitination and degradation of p53. Inhibition of either PAI-1 or p53 can prevent the aggravated renal injury and inflammation caused by loss of CUL4B. Our work has identified the kidney-protective role of CUL4B against acute injury.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
CUL4B通过抑制p53/PAI-1信号传导保护肾脏免受急性损伤。
肾毒素、缺血再灌注(IR)或败血症引起的急性肾损伤(AKI)具有较高的发病率和死亡率。揭示AKI的新机制有助于开发新的治疗策略。Cullin 4B (CUL4B)是CUL4B- ring E3泛素连接酶(CRL4B)复合物中的支架蛋白。在这里,我们证明CUL4B可以保护肾脏免受顺铂和IR引起的急性损伤。在顺铂或IR治疗后,CUL4B在小鼠小管上皮细胞(TECs)中上调。肾脏CUL4B的丢失加重了顺铂和IR引起的TECs的肾损伤、炎症和凋亡。转录组分析显示Cul4b缺陷增强损伤诱导的PAI-1表达。CUL4B通过促进多泛素化和p53降解来抑制PAI-1的表达。抑制PAI-1或p53均可预防CUL4B缺失引起的肾损伤和炎症加重。我们的工作已经确定了CUL4B对急性损伤的肾脏保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
文献相关原料
公司名称
产品信息
索莱宝
protease inhibitor
索莱宝
Blasticidin S hydrochloride
来源期刊
Cell Death & Disease
Cell Death & Disease CELL BIOLOGY-
CiteScore
15.10
自引率
2.20%
发文量
935
审稿时长
2 months
期刊介绍: Brought to readers by the editorial team of Cell Death & Differentiation, Cell Death & Disease is an online peer-reviewed journal specializing in translational cell death research. It covers a wide range of topics in experimental and internal medicine, including cancer, immunity, neuroscience, and now cancer metabolism. Cell Death & Disease seeks to encompass the breadth of translational implications of cell death, and topics of particular concentration will include, but are not limited to, the following: Experimental medicine Cancer Immunity Internal medicine Neuroscience Cancer metabolism
期刊最新文献
MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway. ZBP1-mediated PANoptosis is a crucial lethal form in diverse keratinocyte death modalities in UVB-induced skin injury. Ferroptosis triggers mitochondrial fragmentation via Drp1 activation. Positive feedback loop involving AMPK and CLYBL acetylation links metabolic rewiring and inflammatory responses. RNAi-based ALOX15B silencing augments keratinocyte inflammation in vitro via EGFR/STAT1/JAK1 signalling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1